Modalis Therapeutics
Tokyo
About Modalis Therapeutics
Modalis Therapeutics Corporation is an biotech company focusing on developing transformative therapeutics for unmet medical needs using its proprietary technologies on CRISPR and protein engineering platforms. The company has a strong foundation on intellectual property licensed from the University of Tokyo.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $38.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jun 2025)
- Ticker: tyo:4883
- Website: modalistx.comjp
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/modalis-therapeutics-52939 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.